SMTL ID : 3hb5.1

Binary and ternary crystal structures of a novel inhibitor of 17 beta-HSD type 1: a lead compound for breast cancer therapy

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 29 residues within 4Å: Chain A: G.9, C.10, S.11, S.12, G.13, I.14, G.15, T.35, L.36, R.37, D.38, T.41, L.64, D.65, V.66, R.67, N.90, A.91, G.92, L.93, T.140, G.141, Y.155, K.159, C.185, G.186, V.188, T.190, F.192 29 PLIP interactions: 29 interactions with chain A Hydrophobic interactions: A:V.188 Hydrogen bonds: A:G.9, A:G.9, A:C.10, A:S.11, A:S.11, A:S.12, A:S.12, A:I.14, A:G.15, A:R.37, A:R.37, A:D.38, A:T.41, A:D.65, A:V.66, A:N.90, A:N.90, A:G.92, A:K.159, A:V.188, A:T.190 Water bridges: A:G.9, A:G.9, A:K.159, A:K.159, A:T.190 Salt bridges: A:R.37 pi-Cation interactions: A:R.37 NAP.3: 29 residues within 4Å: Chain B: G.9, C.10, S.11, S.12, G.13, I.14, G.15, T.35, L.36, R.37, D.38, T.41, L.64, D.65, V.66, R.67, N.90, A.91, G.92, L.93, T.140, G.141, Y.155, K.159, C.185, G.186, V.188, T.190, F.192 30 PLIP interactions: 30 interactions with chain B Hydrophobic interactions: B:V.188 Hydrogen bonds: B:G.9, B:G.9, B:C.10, B:S.11, B:S.11, B:S.12, B:S.12, B:I.14, B:G.15, B:R.37, B:R.37, B:D.38, B:D.65, B:D.65, B:V.66, B:N.90, B:N.90, B:G.92, B:Y.155, B:K.159, B:V.188, B:T.190, B:T.190 Water bridges: B:G.9, B:G.9, B:K.159, B:K.159 Salt bridges: B:R.37 pi-Cation interactions: B:R.37

2 x E2B: 3-{[(9beta,14beta,16alpha,17alpha)-3,17-dihydroxyestra-1,3,5(10)-trien-16-yl]methyl}benzamide(Non-covalent)

E2B.2: 17 residues within 4Å: Chain A: G.94, L.95, S.142, V.143, G.144, L.149, N.152, Y.155, C.185, F.192, V.196, Y.218, H.221, V.225, F.259, M.279, E.282 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.143, A:L.149, A:Y.155, A:F.192, A:V.225, A:V.225, A:F.259 Hydrogen bonds: A:L.95, A:L.95, A:V.143, A:G.144, A:C.185, A:H.221 E2B.4: 17 residues within 4Å: Chain B: G.94, L.95, S.142, V.143, G.144, L.149, N.152, Y.155, C.185, F.192, V.196, Y.218, H.221, V.225, F.259, M.279, E.282 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:V.143, B:L.149, B:Y.155, B:F.192, B:V.225, B:V.225, B:F.259 Hydrogen bonds: B:L.95, B:L.95, B:V.143, B:G.144, B:C.185, B:H.221, B:E.282

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mazumdar, M. et al., Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy. Biochem.J. (2009)

Release Date

2009-12-15

Peptides

Estradiol 17-beta-dehydrogenase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
X

B
X

Estradiol 17-beta-dehydrogenase 1

Related Entries With Identical Sequence